Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
  1. 4 Exercise or conversion Chief Scientific Officer acquired 30,000 shares (option exercise)
  2. 4 Other acquisition Chief Financial Officer acquired 5,000 shares (code O)
  3. 4 Exercise or conversion Chief Executive Officer acquired 10,000 shares (option exercise)
  4. 4 Derivatives Options or other derivatives
  5. 4 Exercise or conversion Director acquired 30,000 shares (option exercise)
  6. 4 Shares withheld for taxes Chief Executive Officer gave up 4,323 shares (to pay taxes)
  7. 4 Shares withheld for taxes General Counsel, Secretary gave up 767 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Medical Officer gave up 3,081 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Executive Officer gave up 4,292 shares (to pay taxes)
  10. 4 Grant or award Chief Financial Officer acquired 40,000 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Chief Medical Officer acquired 30,000 shares (grant or award)
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 3,819 shares (to pay taxes)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale CFO and Treasurer sold 23,532 shares at an average $3.47 ($81,541)
  16. 4 Shares withheld for taxes CFO and Treasurer gave up 752 shares (to pay taxes)
  17. 4 Grant or award Director acquired 5,000 shares (grant or award)
  18. 4 Grant or award Director acquired 5,000 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 8 of 13 · 246 filings